Ipecacuanha

# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider.  WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery.  The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements.  WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

# Overview
Ipecacuanha is a OTC emetic that is FDA approved for the treatment of of Poisoning, acute by inducing vomiting.   Common adverse reactions include Diarrhea, Stomach cramps, Myalgia and Lethargy.

# Adult Indications and Dosage

## FDA-Labeled Indications and Dosage (Adult)

### Indications
- Poisoning, acute
- to induce NAUSEA AND VOMITING

### Dosage
- Allow 3 or 4 pellets to dissolve in the mouth 3 times a day until symptoms are relieved or as directed by a health professional.

## Off-Label Use and Dosage (Adult)

### Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Ipecacuanha in adult patients.

### NonGuideline-Supported Use
There is limited information regarding Off-Label NonGuideline-Supported Use of Ipecacuanha in adult patients.

# Pediatric Indications and Dosage

## FDA-Labeled Indications and Dosage (Pediatric)

### Indications
- Poisoning, acute

### Dosage
- Allow 3 or 4 pellets to dissolve in the mouth 3 times a day until symptoms are relieved or as directed by a health professional.

## Off-Label Use and Dosage (Pediatric)

### Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Ipecacuanha in pediatric patients.

### NonGuideline-Supported Use
There is limited information regarding Off-Label NonGuideline-Supported Use of Ipecacuanha in pediatric patients.

# Contraindications
There is limited information regarding Ipecacuanha Contraindications in the drug label.

# Warnings
There is limited information regarding Ipecacuanha Warnings' in the drug label.

# Adverse Reactions

## Clinical Trials Experience
- Diarrhea
- Stomach cramps
- Myalgia
- Lethargy

## Postmarketing Experience
There is limited information regarding Ipecacuanha Postmarketing Experience in the drug label.

# Drug Interactions
There is limited information regarding Ipecacuanha Drug Interactions in the drug label.

# Use in Specific Populations

### Pregnancy
Pregnancy Category (FDA):
- If pregnant or breast-feeding, ask a health professional before use
Pregnancy Category (AUS):
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Ipecacuanha in women who are pregnant.

### Labor and Delivery
There is no FDA guidance on use of Ipecacuanha during labor and delivery.

### Nursing Mothers
- If pregnant or breast-feeding, ask a health professional before use

### Pediatric Use
There is no FDA guidance on the use of Ipecacuanha with respect to pediatric patients.

### Geriatic Use
There is no FDA guidance on the use of Ipecacuanha with respect to geriatric patients.

### Gender
There is no FDA guidance on the use of Ipecacuanha with respect to specific gender populations.

### Race
There is no FDA guidance on the use of Ipecacuanha with respect to specific racial populations.

### Renal Impairment
There is no FDA guidance on the use of Ipecacuanha in patients with renal impairment.

### Hepatic Impairment
There is no FDA guidance on the use of Ipecacuanha in patients with hepatic impairment.

### Females of Reproductive Potential and Males
There is no FDA guidance on the use of Ipecacuanha in women of reproductive potentials and males.

### Immunocompromised Patients
There is no FDA guidance one the use of Ipecacuanha in patients who are immunocompromised.

# Administration and Monitoring

### Administration
- Oral

### Monitoring
There is limited information regarding Monitoring of Ipecacuanha in the drug label.

# IV Compatibility
There is limited information regarding IV Compatibility of Ipecacuanha in the drug label.

# Overdosage
There is limited information regarding Overdose of Ipecacuanha in the drug label.

# Pharmacology
There is limited information regarding Ipecacuanha Pharmacology in the drug label.

## Mechanism of Action
There is limited information regarding Ipecacuanha Mechanism of Action in the drug label.

## Structure
IPECACUANHA 3X
(Ipecac)
Lactose, sucrose.

## Pharmacodynamics
There is limited information regarding Pharmacodynamics of Ipecacuanha in the drug label.

## Pharmacokinetics
There is limited information regarding Pharmacokinetics of Ipecacuanha in the drug label.

## Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Ipecacuanha in the drug label.

# Clinical Studies
There is limited information regarding Clinical Studies of Ipecacuanha in the drug label.

# How Supplied
There is limited information regarding Ipecacuanha How Supplied in the drug label.

## Storage
- Store at room temperature.

# Images

## Drug Images

## Package and Label Display Panel

### LABEL

### Ingredients and Appearance

# Patient Counseling Information
- QUESTIONS?

# Precautions with Alcohol
- Alcohol-Ipecacuanha interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

# Brand Names
- IPECACUANHA

# Look-Alike Drug Names
There is limited information regarding Ipecacuanha Look-Alike Drug Names in the drug label.

# Drug Shortage Status

# Price